“…The use of AAV in human ROs is relatively limited at the moment, but studies have reported varying efficiency of transduction, which could be attributed to age of treatment, time of harvesting, vector tropisms, viral titre, the promotor used and sensitivity of detection of the transgene, e.g. antibody versus intrinsic fluorescence of a reporter (Gonzalez-Cordero et al, 2018, Tornabene et al, 2019, Quinn et al, 2019, Khabou et al, 2018. Here we demonstrate highly efficient transduction using an AAV2/5 vector with RP2 under the control of a CAG promoter.…”